Cite
HARVARD Citation
, . et al. (2017). ITPA Deficiency and Ribavirin Level are Still Predictive of Anaemia in HCV–HIV-Coinfected Patients Receiving Ribavirin Combined with a First-Generation DAA (ANRS HC27 Study). Antiviral therapy. 22 (6), pp. 461-469. [Online].